Sodium–glucose Cotransporter 2 Inhibitors’ Rise to the Backbone of Heart Failure Management: A Clinical Review

Sodium–glucose cotransporter (SGLT) 2 inhibitors, or gliflozins, have quickly risen to prominence within the cardiovascular field due to their substantial benefit in the management of heart failure with reduced ejection fraction (HFrEF). SGLT channels are present throughout the body in various isofo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Heart international 2021-01, Vol.15 (1), p.42-48
Hauptverfasser:	Rohant, Namit, Kennedy, Jamie LW
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Clinical outcomes Diabetes Glucose Heart failure Hospitalization Inhibitor drugs Mortality
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!